A citation-based method for searching scientific literature

Gianluca Businello, Francesca Galuppini, Matteo Fassan. Best Pract Res Clin Gastroenterol 2021
Times Cited: 11







List of co-cited articles
31 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.
Razvan Cristescu, Jeeyun Lee, Michael Nebozhyn, Kyoung-Mee Kim, Jason C Ting, Swee Seong Wong, Jiangang Liu, Yong Gang Yue, Jian Wang, Kun Yu,[...]. Nat Med 2015
36


Early HER2 dysregulation in gastric and oesophageal carcinogenesis.
Matteo Fassan, Luca Mastracci, Federica Grillo, Vittorina Zagonel, Sara Bruno, Giorgio Battaglia, Francesca Pitto, Donato Nitti, Tiziana Celiento, Giovanni Zaninotto,[...]. Histopathology 2012
55
36

PD-L1 expression in gastroesophageal dysplastic lesions.
Matteo Fassan, Stefano Brignola, Gianmaria Pennelli, Giulia Alberti, Valentina Angerilli, Alessandra Bressan, Antonio Pellino, Cristiano Lanza, Roberta Salmaso, Sara Lonardi,[...]. Virchows Arch 2020
16
36

High-throughput Protein and mRNA Expression-based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications.
Sangjeong Ahn, So-Jeong Lee, Yonugkeum Kim, Ahrong Kim, Nari Shin, Kyung Un Choi, Chang-Hun Lee, Gi Yeong Huh, Kyong-Mee Kim, Namrata Setia,[...]. Am J Surg Pathol 2017
59
27

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
27

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Yung-Jue Bang, Eric Van Cutsem, Andrea Feyereislova, Hyun C Chung, Lin Shen, Akira Sawaki, Florian Lordick, Atsushi Ohtsu, Yasushi Omuro, Taroh Satoh,[...]. Lancet 2010
27

Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes.
Irene Gullo, Federica Grillo, Luca Mastracci, Alessandro Vanoli, Fatima Carneiro, Luca Saragoni, Francesco Limarzi, Jacopo Ferro, Paola Parente, Matteo Fassan. Pathologica 2020
16
27

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
27

Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis.
Anna Yemelyanova, Russell Vang, Malti Kshirsagar, Dan Lu, Morgan A Marks, Ie Ming Shih, Robert J Kurman. Mod Pathol 2011
322
18

Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical Trial.
Manish A Shah, Yung-Jue Bang, Florian Lordick, Maria Alsina, Meng Chen, Stephen P Hack, Jean Marie Bruey, Dustin Smith, Ian McCaffery, David S Shames,[...]. JAMA Oncol 2017
164
18

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.
Charles S Fuchs, Jiri Tomasek, Cho Jae Yong, Filip Dumitru, Rodolfo Passalacqua, Chanchal Goswami, Howard Safran, Lucas Vieira Dos Santos, Giuseppe Aprile, David R Ferry,[...]. Lancet 2014
18


Age-specific trends in incidence of noncardia gastric cancer in US adults.
William F Anderson, M Constanza Camargo, Joseph F Fraumeni, Pelayo Correa, Philip S Rosenberg, Charles S Rabkin. JAMA 2010
316
18



Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design.
Daniel Vt Catenacci, Anteneh Tesfaye, Mohamed Tejani, Eric Cheung, Peter Eisenberg, Aaron J Scott, Clarence Eng, James Hnatyszyn, Neyssa Marina, Janine Powers,[...]. Future Oncol 2019
40
18

Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm.
Yoshiaki Nakamura, Akihito Kawazoe, Florian Lordick, Yelena Y Janjigian, Kohei Shitara. Nat Rev Clin Oncol 2021
48
18

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer.
Kohei Shitara, Yung-Jue Bang, Satoru Iwasa, Naotoshi Sugimoto, Min-Hee Ryu, Daisuke Sakai, Hyun-Cheol Chung, Hisato Kawakami, Hiroshi Yabusaki, Jeeyun Lee,[...]. N Engl J Med 2020
309
18

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.
Hansjochen Wilke, Kei Muro, Eric Van Cutsem, Sang-Cheul Oh, György Bodoky, Yasuhiro Shimada, Shuichi Hironaka, Naotoshi Sugimoto, Oleg Lipatov, Tae-You Kim,[...]. Lancet Oncol 2014
18

Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.
Christine P Petersen, Victoria G Weis, Ki Taek Nam, Josane F Sousa, Barbara Fingleton, James R Goldenring. Gastroenterology 2014
74
18

FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma.
U Sahin, Ö Türeci, G Manikhas, F Lordick, A Rusyn, I Vynnychenko, A Dudov, I Bazin, I Bondarenko, B Melichar,[...]. Ann Oncol 2021
55
18

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.
Zefang Tang, Chenwei Li, Boxi Kang, Ge Gao, Cheng Li, Zemin Zhang. Nucleic Acids Res 2017
18

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.
Kohei Shitara, Eric Van Cutsem, Yung-Jue Bang, Charles Fuchs, Lucjan Wyrwicz, Keun-Wook Lee, Iveta Kudaba, Marcelo Garrido, Hyun Cheol Chung, Jeeyun Lee,[...]. JAMA Oncol 2020
302
18

Next-generation sequencing and biomarkers for gastric cancer: what is the future?
Akihito Kawazoe, Kohei Shitara. Ther Adv Med Oncol 2019
8
25

WGCNA: an R package for weighted correlation network analysis.
Peter Langfelder, Steve Horvath. BMC Bioinformatics 2008
18

Microsatellite instability and gastric non-invasive neoplasia in a high risk population in Cesena, Italy.
M Rugge, G Bersani, R Bertorelle, G Pennelli, V M Russo, F Farinati, D Bartolini, M Cassaro, V Alvisi. J Clin Pathol 2005
17
18

Epstein-Barr virus associated gastric dysplasia: a new rare entity?
Valentina Angerilli, Francesca Galuppini, Gianmaria Pennelli, Giuseppe Nicolo' Fanelli, Emanuele S G d'Amore, Mauro Michelotto, Pierluigi Pilati, Gaya Spolverato, Salvatore Pucciarelli, Marco Scarpa,[...]. Virchows Arch 2022
2
100

Molecular Landscapes of Gastric Pre-Neoplastic and Pre-Invasive Lesions.
Gianluca Businello, Valentina Angerilli, Paola Parente, Stefano Realdon, Edoardo Savarino, Fabio Farinati, Federica Grillo, Alessandro Vanoli, Francesca Galuppini, Silvia Paccagnella,[...]. Int J Mol Sci 2021
6
33


The implementation of a commercially available multi-gene profile test for breast cancer characterization in a department of pathology: what have we learned from the first 100 cases?
Cristina Pelliccia, Emanuele Caselli, Martina Mandarano, Rachele Del Sordo, Guido Bellezza, Angelo Sidoni. Virchows Arch 2021
2
50

Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications.
Jiwon Koh, Keun-Wook Lee, Soo Kyung Nam, An Na Seo, Ji-Won Kim, Jin Won Kim, Do Joong Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee. Oncologist 2019
11
9

Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology.
Magdalena Cisło, Agata Anna Filip, George Johan Arnold Offerhaus, Bogumiła Ciseł, Karol Rawicz-Pruszyński, Małgorzata Skierucha, Wojciech Piotr Polkowski. Oncotarget 2018
44
9

PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis.
Lihu Gu, Manman Chen, Dongyu Guo, Hepan Zhu, Wenchao Zhang, Junhai Pan, Xin Zhong, Xinlong Li, Haoran Qian, Xianfa Wang. PLoS One 2017
133
9

Gastric cancer--actual multimodality treatment strategies.
Hans-Joachim Meyer, Jane Nutzmann, Hansjochen Wilke. Pol Przegl Chir 2012
1
100

Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma.
C Mariette, F Carneiro, H I Grabsch, R S van der Post, W Allum, Giovanni de Manzoni. Gastric Cancer 2019
72
9

Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer.
Koji Ando, Eiji Oki, Hiroshi Saeki, Zhao Yan, Yasuo Tsuda, Gen Hidaka, Yuta Kasagi, Hajime Otsu, Hiroyuki Kawano, Hiroyuki Kitao,[...]. Cancer Med 2015
46
9

p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort.
Isabelle Schoop, Saffiyeh Saboor Maleki, Hans-Michael Behrens, Sandra Krüger, Jochen Haag, Christoph Röcken. Hum Pathol 2020
9
11

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
9

Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors.
Aino Paasinen-Sohns, Viktor H Koelzer, Angela Frank, Julian Schafroth, Aline Gisler, Melanie Sachs, Anne Graber, Sacha I Rothschild, Andreas Wicki, Gieri Cathomas,[...]. Neoplasia 2017
17
9

Reliability of liquid biopsy analysis: an inter-laboratory comparison of circulating tumor DNA extraction and sequencing with different platforms.
Thibaud Koessler, Viola Paradiso, Salvatore Piscuoglio, Ronny Nienhold, Liza Ho, Yann Christinat, Luigi M Terracciano, Gieri Cathomas, Andreas Wicki, Thomas A McKee,[...]. Lab Invest 2020
8
12

FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors.
Leigh Marcus, Steven J Lemery, Patricia Keegan, Richard Pazdur. Clin Cancer Res 2019
474
9

Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
Raul S Gonzalez, Susan Messing, Xin Tu, Loralee A McMahon, Christa L Whitney-Miller. Hum Pathol 2016
37
9

A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability.
Mauricio P Pinto, Miguel Córdova-Delgado, Ignacio N Retamal, Matías Muñoz-Medel, M Loreto Bravo, Doris Durán, Francisco Villanueva, César Sanchez, Francisco Acevedo, Sebastián Mondaca,[...]. Cancers (Basel) 2020
6
16

Gastric adenocarcinoma.
Jaffer A Ajani, Jeeyun Lee, Takeshi Sano, Yelena Y Janjigian, Daiming Fan, Shumei Song. Nat Rev Dis Primers 2017
272
9

Preservation of Epstein-Barr virus status and mismatch repair protein status along the metastatic course of gastric cancer.
Bastian Dislich, Nicola Blaser, Martin D Berger, Beat Gloor, Rupert Langer. Histopathology 2020
7
14

Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis.
M Constanza Camargo, Woo-Ho Kim, Anna Maria Chiaravalli, Kyoung-Mee Kim, Alejandro H Corvalan, Keitaro Matsuo, Jun Yu, Joseph J Y Sung, Roberto Herrera-Goepfert, Fernando Meneses-Gonzalez,[...]. Gut 2014
237
9

A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies.
Steffen Boettcher, Peter G Miller, Rohan Sharma, Marie McConkey, Matthew Leventhal, Andrei V Krivtsov, Andrew O Giacomelli, Waihay Wong, Jesi Kim, Sherry Chao,[...]. Science 2019
147
9

A next-generation tissue microarray (ngTMA) protocol for biomarker studies.
Inti Zlobec, Guido Suter, Aurel Perren, Alessandro Lugli. J Vis Exp 2014
47
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.